Introduction {#Sec1}
============

Foot ulceration is the most common complication in diabetes, with a lifetime risk of 25% \[[@CR1]\]. The condition portends significant excess morbidity and mortality in individuals with diabetes, who are already facing reduced life expectancy and an unfavourable prognosis \[[@CR1]--[@CR5]\]. Established aetiological risk factors for foot ulceration in diabetes are suboptimally controlled diabetes, peripheral neuropathy, peripheral vascular disease, foot deformity and previous foot ulceration \[[@CR1], [@CR6]\].

Diabetic foot ulceration is a global public health issue, with a prevalence of 13.0% in North America and 5.1% in Europe \[[@CR7]\]. The incidence in Europe is around 2% per year \[[@CR8]\]. Costs of care are double those seen in individuals without ulceration \[[@CR9]\], with the total cost associated with treatment being as high as €10 billion per year in Europe \[[@CR8]\]. The incidence of foot ulcers is 2.2% per annum in the UK, and an average of 6000 people with diabetes each year undergo amputation \[[@CR10], [@CR11]\]. The financial burden is significant in terms of both healthcare costs and long-term consequences. The annual UK National Health Service expenditure on diabetes foot-related care in 2010--2011 was estimated to be £580 million (US\$748 million), representing around 0.6% of total expenditure \[[@CR12]\]. Within 5 years (2014--2015), after accounting for inflation, estimates rose to between £972 million and £1.13 billion (US\$1.29--1.50 billion), with two-thirds of these costs spent on care for foot ulceration in primary, community and outpatient settings \[[@CR13]\]. Consequently, better precision in understanding the risk calculus in relation to the development of diabetic foot ulcers and the likelihood of death in such individuals will result in reduced health service costs and potential cost savings in the longer term.

Previous epidemiological studies have shown a strong association between socioeconomic disadvantage and the prevalence of diabetes \[[@CR14], [@CR15]\]. In the general population, mortality is greater in those from a more disadvantaged socioeconomic situation, principally as a result of cardiovascular disease \[[@CR16]\]. In the presence of diabetes, however, mortality rates are significantly greater in individuals who live in relatively deprived areas \[[@CR17]\]. Furthermore, depression has been found to be associated with a 2.3-fold increase in mortality vs no depression in individuals with diabetes \[[@CR18]\]. Psychological factors other than coded diagnoses are difficult to quantify in epidemiological studies, but are clearly important.

The literature on the association between social deprivation and foot ulceration in individuals with diabetes is inconsistent. Two UK studies have shown no association between socioeconomic disadvantage and foot ulceration \[[@CR19], [@CR20]\]. Conversely, one Scottish study considered healthcare accessibility as well as socioeconomic disadvantage in the population and demonstrated evidence of increased foot ulceration in the more disadvantaged areas within Scotland \[[@CR21]\]. The Eurodiale study has reported that low health-related quality of life is predictive of major amputation and mortality \[[@CR22]\].

Few studies have looked at social disadvantage as an independent risk factor in diabetes foot ulceration and as a risk factor for mortality in those with a foot ulcer. The first aim of this study was to determine whether social deprivation is an independent predictor of foot ulceration in people with diabetes in a population with significantly varying levels of social disadvantage. Second, we tested the hypothesis that foot ulceration and level of social disadvantage independently predict all-cause mortality in individuals with type 2 diabetes.

Methods {#Sec2}
=======

We examined pseudo-anonymised electronic health records from a retrospective cohort of all men and women aged 16--89 years attending 42 general practices in central and eastern Cheshire, UK. The area is a mixed urban and rural environment with a wide range of socioeconomic situations, from significantly disadvantaged urban areas to highly affluent suburbs. The total population of the geographical area studied was 475,000, and the prevalence of significant social disadvantage (based on multiple measures) was 23%.

Individuals were eligible for inclusion if they had a diagnosis of diabetes prior to cohort entry at 1 January 2004 to allow long-term follow-up and no prior history of foot ulceration. A data search was performed through the centralised data facility afforded by Egton Medical Information Systems (EMIS), a commercial organisation that provides health information for nearly all family practices in Cheshire. Permission for this study was sought from and granted by the local information governance and ethics committees. Informed consent was not required as all data were anonymised.

Exposure {#FPar1}
--------

For the main search, we included all individuals using the relevant READ codes for type 1 and type 2 diabetes. READ codes are used in a hierarchical clinical coding system of more than 80,000 terms that is used in general practice across the UK \[[@CR23]\]. The READ codes used in this study are available from the Clinical Codes repository ([www.clinicalcodes.org](http://www.clinicalcodes.org)) \[[@CR24]\]. We examined the electronic health records of the included individuals to determine the presence of foot ulcers occurring after 1 January 2004 using the relevant READ codes.

Outcomes {#FPar2}
--------

For all individuals, the outcomes were foot ulceration and all-cause mortality during the study period. Currently, the reporting of deaths within UK primary care is well established, and if an individual dies in secondary or tertiary care then a general practitioner (GP) must be notified of the death. The date of death was ascertained from GP records. We controlled for survival bias by following all participants from the same point in time: a landmark of 6 months post 1 January 2004. Follow-up was censored at death, the date an individual left the practice or the final data collection for the practice (30 June 2015), whichever occurred first.

Variables {#FPar3}
---------

Data on potential confounders, including age on the date of inclusion, sex, diabetes type and duration, hypertension (defined as BP \>140/90 mmHg on two or more readings, as per READ codes), diabetes treatment (oral medication, glucagon-like peptide 1 or insulin), metabolic control (through HbA~1c~) and smoking habits (unreported status, current/ex-smoker and non-smoker), were recorded, as was the prescribing of statins and antihypertensive agents.

The Townsend index of deprivation (categorised by quintiles) was determined in our study population \[[@CR25]\]. This information is available in GP records linking the postcode of the individual with UK census data. The Townsend index was devised to provide a material measure of deprivation and socioeconomic disadvantage in a population, and derives from census variables taken originally from the 1991 UK census, with numerically higher values suggesting greater socioeconomic deprivation. The four variables that comprise the Townsend index are as follows: (1) unemployment as a percentage of those aged 16 years and over who are economically active; (2) non-car ownership as a percentage of all households; (3) non-home ownership as a percentage of all households; and (4) household overcrowding. All four variables are standardised using a *z* score and then summed to obtain a single value. Positive values of the Townsend index are associated with geographic areas with high deprivation, while indices with negative values relate to relative affluence. While the central and eastern Cheshire region is predominantly of white European ethnicity, records pertaining to ethnicity were only available for a small proportion (\<4%) of the population and have therefore not been included.

Assays {#FPar4}
------

Blood glucose, lipid profile and serum creatinine were determined using automated clinical chemistry analysers. Samples assayed at Leighton Hospital used Ortho VITROS chemistry analysers (Ortho Clinical Diagnostics, High Wycombe, UK), and those assayed at Macclesfield District General Hospital used Beckman Coulter chemistry analysers (High Wycombe, UK). HbA~1c~ was determined using the using the Menarini Hb9210 semi-automated analyser (Menarini Diagnostics, Winnersh, UK). eGFR was calculated using the abbreviated modification of diet in renal disease equation \[[@CR26]\]: eGFR (ml^−1^ min^−1^ 1.73 m^−2^) = 186 × (creatinine/88.4)^−1.154^ × (age)^−0.203^ × (0.742 if female) × (1.210 if black).

Statistical analyses {#FPar5}
--------------------

Data were analysed using the statistical package Intercooled Stata version 13.1 (StataCorp, College Station, TX, USA). Data are expressed as mean (95% CI), mean (range), median (range) or number (percentage) where relevant. A linear regression analysis was used to determine the association between age and the presence of foot ulceration. We used the χ^2^ test or Fisher's exact test to compare categorical variables, *t* tests or ANOVA for comparing continuous variables. Kaplan--Meier curves were used to compare survival probabilities for men and women with or without a history of foot ulceration. We investigated proportional hazards assumptions using tests and graphical diagnostics based on scaled Schoenfeld residuals. A test of the proportional hazards assumption was obtained by correlating the corresponding set of scaled Schoenfeld residuals with the Kaplan--Meier estimate of the survival distribution.

We fitted Poisson regressions from the occurrence (count) of an incident foot ulceration episode (per person) during follow-up, and report unadjusted and age-adjusted incidence rate ratios (and their 95% CI) from transformed coefficients using the Poisson command in Stata. An assessment of equidispersion was performed using post-estimation tests (data not shown), following Poisson regression for deviance goodness of fit and Pearson goodness of fit. We used logistic regression analyses to estimate the ORs and 95% CI for developing foot ulceration by quintile of Townsend index score.

We developed shared frailty multivariable survival Cox proportional hazard models, clustering for GP practice, to estimate HRs (and their 95% CI) for mortality in those with and without foot ulceration during the study period, adjusting for age (per year), sex, HbA~1c~ (per 10 mmol/mol), type of diabetes, smoking status, a history of cerebrovascular disease or myocardial infarction, hypertension, and a history of statin, aspirin, β-blocker or metformin prescription. We tested for interactions by adding terms for foot ulceration and Townsend index score (per quintile). Tests for statistically significant interactions used the Wald test (Stata command *testparm*); if the interaction term was not significant, this was excluded from the final model. We used the Stata command *estat* concordance to calculate the rank parameters Harrell's C and Somers' D as a measure of the ordinal predictive power of a model \[[@CR27]\].

Results {#Sec3}
=======

A total of 13,955 individuals (mean age 69.4 years) with diabetes were included in the analyses (Table [1](#Tab1){ref-type="table"}). Of these, 1370 (9.8%) had type 1 diabetes and 12,585 (90.2%) were diagnosed with type 2 diabetes (Table [2](#Tab2){ref-type="table"}). The incidence of foot ulceration increased with age (β = 4.3, *p* \< 0.001), was more common in the elderly (\>70 years old) and in individuals with type 2 compared with type 1 diabetes (8.6% \[*n* = 1081\] vs 4.8% \[*n* = 66\], χ^2^ = 23.3; *p* \< 0.001). In the full cohort, stratified by sex, the occurrence of foot ulceration rate was similar (508/6011 \[8.4%\]) in women and men (639/7944, \[8.0%\]). However, amongst those who developed foot ulceration \[*n* = 1147\], a greater proportion were male (55.7% vs 44.3%; male versus female, *p* = 0.0001; Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}). At baseline, greater proportions of individuals with foot ulceration had hypertension, cerebrovascular disease, peripheral vascular disease and a previous myocardial infarction (all *p* \< 0.01, Table [1](#Tab1){ref-type="table"}). Mean systolic and diastolic blood pressure and levels of creatinine and LDL-cholesterol were greater in the presence of foot ulceration in individuals with type 2 diabetes (Table [2](#Tab2){ref-type="table"}). No differences were observed in type 1 diabetes for these covariates.Table 1 Baseline characteristics of all individuals by the presence or absence of foot ulcerationVariableTotal populationFoot ulcer^a^No foot ulcer*p* value^b^(*n*=1147)(*n*=12,808)Age, years74.2 (73.3, 74.2)69.0 (68.8, 69.3)\<0.001Sex, *n* (%)  Male639 (55.7)7305 (57.0)0.518  Female508 (44.3)5503 (43.0)0.565Age categories, *n* (%)  \<40 years15 (1.3)690 (5.4)0.485  40--49 years40 (3.5)773 (6.0)0.505  50--59 years112 (9.8)1495 (11.7)0.542  60--69 years194 (16.9)2582 (20.2)0.274  \>70 years786 (68.5)7268 (56.7)\<0.001Hypertension, *n* (%)815 (71.0)7704 (60.2)\<0.001Cerebrovascular disease, *n* (%)124 (10.8)836 (6.5)\<0.001Peripheral vascular disease, *n* (%)168 (14.7)535 (4.2)\<0.001Previous myocardial infarction, *n* (%)209 (18.2)1483 (11.6)\<0.001Congestive cardiac failure, *n* (%)224 (19.5)997 (7.8)\<0.001Smoking status, *n* (%)  Current/ex-smoker375 (32.7)4548 (35.5)0.272  Non-smoker427 (37.2)3748 (29.3)0.001  Unreported smoking status345 (30.1)4512 (35.2)0.053HbA~1c~, mmol/mol60.7 (59.7, 61.8)59.4 (59.1, 59.8)0.024HbA~1c~, %7.7 (7.6, 7.8)7.6 (7.6, 7.6)0.024Systolic BP, mmHg143 (142, 147)141 (140, 142)\<0.001Diastolic BP, mmHg78 (77, 79)79 (78, 79)0.01Creatinine, μmol/l100 (97, 102)91 (90, 92)\<0.001Total cholesterol, mmol/l4.6 (4.5, 4.6)4.7 (4.6, 4.7)0.027LDL-cholesterol, mmol/l2.6 (2.5, 2.6)2.7 (2.6, 2.7)0.009HDL-cholesterol, mmol/l1.24 (1.21, 1.27)1.27 (1.27, 1.28)0.061Statin treatment, *n* (%)675 (58.9)6847 (53.5)\<0.001Townsend index score−0.6 (−0.7, −0.4)−1.2 (−1.2, −1.1)\<0.001Data are the most recent measure within 1 year of study entryContinuous data are presented as mean (95% CI)^a^Foot ulceration identified during follow-up^b^From test of proportions, χ^2^ tests (categorical variables) or ANOVA (continuous) for differences by the presence or absence of foot ulceration Table 2 Baseline characteristics of all individuals by type of diabetes and foot ulceration statusVariableType 2 diabetesType 1 diabetesFoot ulcer^a^No foot ulcer*p* value^b^Foot ulcer^a^No foot ulcer*p* value^b^(*n*=1081)(*n*=11,504)(*n*=66)(*n*=1304)Age, years74.2 (73.5, 74.9)71.7 (71.5, 72.0)\<0.00159.33 (55.3, 63.4)45.3 (44.4, 46.2)\<0.001Sex, *n* (%)  Male594 (54.9)6569 (57.1)0.32245 (68.2)736 (56.4)0.122  Female487 (45.1)4935 (42.9)0.35021 (31.8)568 (43.6)0.286Age categories, *n* (%)  \<40 years8 (0.7)189 (1.6)0.8407 (10.6)501 (38.4)0.132  40--49 years25 (2.3)446 (3.9)0.68415 (22.7)327 (25.1)0.837  50--59 years102 (9.4)1260 (11.0)0.61810 (15.2)235 (18.0)0.817  60--69 years182 (16.8)2456 (21.4)0.14212 (18.2)126 (9.7)0.356  \>70 years764 (70.7)7153 (62.2)\<0.00122 (33.3)115 (8.8)0.002Hypertension, *n* (%)791 (73.2)7478 (65.0)\<0.00124 (36.4)226 (17.3)\<0.001Cerebrovascular disease, *n* (%)118 (10.9)828 (7.2)\<0.0016 (9.1)8 (0.6)\<0.001Peripheral vascular disease, *n* (%)152 (14.1)502 (4.4)\<0.00116 (24.2)33 (2.5)\<0.001Previous myocardial infarction, *n* (%)203 (18.8)1445 (12.6)\<0.0016 (9.1)38 (2.9)0.005Congestive cardiac failure, *n* (%)220 (20.4)979 (8.5)\<0.0014 (6.1)18 (1.4)0.003Smoking status, *n* (%)  Current/ex-smoker345 (31.9)4062 (35.3)0.20430 (45.5)486 (37.3)\<0.001  Non-smoker427 (39.5)3748 (32.6)0.004------  Unreported smoking status309 (28.6)3694 (32.1)0.20036 (54.5)818 (62.7)0.321HbA~1c~, mmol/mol60.1 (59.0, 61.1)58.3 (57.9, 58.7)0.00372.4 (67.6, 77.2)70.0 (68.9, 71.1)0.341HbA~1c~, %7.6 (7.5, 7.7)7.5 (7.4, 7.5)0.0038.8 (8.3, 9.2)8.6 (8.5, 8.7)0.34Systolic BP, mmHg144 (142, 145)141 (141, 142)0.002136 (130, 142)132 (130, 133)0.175Diastolic BP, mmHg78 (77, 79)79 (79, 79)0.00475 (71, 79)75 (74, 76)0.834Creatinine, μmol/l100 (96, 103)91 (90, 92)0.00494 (78, 110)89 (82, 91)0.454Total cholesterol, mmol/l4.6 (4.5, 4.7)4.6 (4.6, 4.7)0.0734.4 (4.0, 4.8)4.8 (4.7, 4.9)0.056LDL-cholesterol, mmol/l2.6 (2.5, 2.6)2.6 (2.6, 2.7)0.0212.5 (2.1, 2.8)2.8 (2.7, 2.9)0.101HDL-cholesterol, mmol/l1.24 (1.21, 1.27)1.26 (1.25, 1.26)0.191.40 (1.18, 1.62)1.52 (1.47, 1.57)0.274Statin treatment, *n* (%)655 (60.6)6605 (57.4)0.04320 (30.3)242 (18.6)0.018Townsend index score−0.6 (−0.8, −0.4)−1.2 (−1.2, −1.1)\<0.001−0.3 (−0.9, 0.4)−1.3 (1.5, 1.2)0.003Data are the most recent measure within 1 year of study entryContinuous data are presented as mean (95% CI)^a^Foot ulceration identified during follow-up^b^From test of proportions, χ^2^ tests (categorical variables) or ANOVA (continuous) for differences by the presence or absence of foot ulceration

Social deprivation and foot ulceration rates {#FPar6}
--------------------------------------------

For those with foot ulceration, there were between one and 15 recorded episodes per person over the follow-up period, with an incidence rate of 0.9% per year. The unadjusted incidence rate ratio for a foot ulcer was 39% lower for individuals with type 1 vs type 2 diabetes (incidence rate ratio 0.61 \[95% CI 0.47, 0.77\], *p* \< 0.001). Individuals in the fifth quintile of deprivation were 77% more likely to develop a foot ulcer over the follow-up period compared with those in the first quintile (OR 1.77 \[95% CI 1.45, 2.14\], *p* \< 0.0001; Fig. [1](#Fig1){ref-type="fig"}).Fig. 1 ORs (95% CI) for the likelihood of developing foot ulceration by quintile of index of multiple deprivation (IMD) in men and women with type 1 and type 2 diabetes

Foot ulceration rates and mortality {#FPar7}
-----------------------------------

Over a median follow-up period of 10.5 years there were 2946 (21.1%) deaths. Age- and sex-adjusted mortality rates in the group with foot ulcers were approximately twice those in the group without a foot ulcer (25.9% vs 14.0%; 41.6 vs 20.5 deaths per 1000 person-years, respectively). In the presence of type 2 and type 1 diabetes, the mortality rates for individuals with foot ulceration were 43.3 (95% CI 39.3, 47.7) and 16.9 (95% CI 9.3, 30.6) per 1000 person-years, respectively. Foot ulceration was associated with an increased risk of mortality in individuals with type 1 diabetes in unadjusted shared frailty Cox proportional hazard models clustered by practice (HR 4.45 \[95% CI 2.29--8.64\]; Fig. [2](#Fig2){ref-type="fig"}), but not after adjustment for age and sex (HR 1.55 \[95% CI 0.79, 3.07\], *p* = 0.20). For individuals with type 2 diabetes, there was an almost doubling of the risk of mortality in unadjusted shared frailty Cox regression analyses clustered by practice (HR 1.93 \[95% CI 1.74--2.15\], *p* \< 0.0001; Fig. [3](#Fig3){ref-type="fig"}), with some attenuation of the size of the effect after age- and sex-adjustment (HR 1.71 \[95% CI 1.54, 1.90\], *p* \< 0.001).Fig. 2 Kaplan--Meier curves for all-cause mortality for no foot ulceration (solid line) and foot ulceration (dashed line) in individuals with type 1 diabetes Fig. 3 Kaplan--Meier curves for all-cause mortality for no foot ulceration (solid line) and foot ulceration (dashed line) in individuals with type 2 diabetes

In similar age- and sex-adjusted models including only those with no prior/current history of foot ulceration, increased deprivation (per quintile) was associated with increased mortality in those with type 2 diabetes (HR 1.13 \[95% CI 1.09, 1.16\], *p* \< 0.0001), but not in those with type 1 diabetes (HR 1.05 \[95% CI 0.86, 1.27\], *p* = 0.063; ESM Table [1](#MOESM1){ref-type="media"}).

Social deprivation and death in individuals with foot ulcer {#FPar8}
-----------------------------------------------------------

Death rates increased per quintile of deprivation in individuals with diabetes and foot ulceration (absolute difference between the first and fifth quintile 19.54 deaths per 1000 person-years; Fig. [4](#Fig4){ref-type="fig"}). Risk of death increased by 14% per quintile of deprivation in a univariable analysis (HR 1.14 \[95% CI 1.10, 1.17%\]) for all individuals. For individuals with type 2 diabetes, the risk of mortality in those who developed foot ulceration increased by 11% per quintile of deprivation (HR 1.11% \[95% CI 1.08%, 1.14%\], *p* \< 0.0001). The association of deprivation with mortality in type 1 diabetes was not significant (HR 1.14 \[95% CI 0.96, 1.36%\], *p* = 0.136).Fig. 4 All-cause mortality rates (95% CI) for foot ulceration by quintile of index of multiple deprivation (IMD) in men and women with type 1 and type 2 diabetes. The horizontal dotted line represents the mean mortality rates (41.6 \[95% CI 37.8, 45.8\]) for men and women with foot ulceration

In shared frailty, multivariable Cox regression analyses clustered by practice, foot ulceration (HR 1.48 \[95% CI 1.33, 1.66\], *p* \< 0.0001) independently predicted long-term mortality after adjustment for age, sex, diabetes type, Townsend index score (HR 1.13 \[95% CI 1.10, 1.17\], per quintile), smoking status, hypertension, statin treatment, β-blocker treatment, metformin use, HbA~1c~ level (per 10 mmol/mol) and insulin use (Fig. [5](#Fig5){ref-type="fig"}). There was no interaction between foot ulceration and the Townsend index score for deprivation (χ^2^ = 1.49; *p* for interaction = 0.475).Fig. 5 Forest plot of multivariable adjusted HRs of all-cause mortality associated with the presence of foot ulceration in men and women with type 2 diabetes. Cox regression models for risk of all-cause mortality were stratified by GP practice and adjusted for age, sex, diabetes type, smoking status, history of hypertension, β-blocker use, HbA~1c~ level, Townsend index of multiple deprivation (IMD) score, metformin use, insulin use and statin use. Harrell's C concordance statistic = 0.73 for model

Discussion {#Sec4}
==========

In this retrospective cohort followed for 10.5 years, individuals with diabetes-related foot ulceration had a higher risk of all-cause mortality than those without a history of foot ulceration. Specifically, after multivariable adjustment, a 48% increased risk of mortality was observed in those who developed a foot ulcer. We also found that social deprivation is an independent predictor of mortality, with the risk of death increasing by 13% per quintile of deprivation (HR 1.13 \[95% CI 1.10, 1.17\]) independent of baseline age, sex, diabetes type, smoking status, hypertension, statin, β-blocker or metformin use, HbA~1c~ level and insulin use. Individuals in the highest quintile of deprivation were 77% more likely to develop a foot ulcer compared with those in the lowest quintile.

Our finding demonstrate similar rates of foot ulcer incidence by sex (8.4% vs 8.0%, females vs males). The lower rates of foot ulceration seen here compared with previous studies may relate to the emphasis placed on foot screening and ulceration-preventative measures among individuals with diabetes in the Cheshire and High Peak Derbyshire areas of the UK over the duration of this study. Overall, our findings from real-world electronic medical records are comparable with those of previous epidemiological reports and add to the current body of evidence. The increased mortality reported here is consistent with previous reports \[[@CR28]--[@CR30]\], including a meta-analysis of 17,830 individuals with diabetes and with or without foot ulceration \[[@CR31]\]. This included six prospective \[[@CR32]--[@CR37]\] and two retrospective cohorts \[[@CR38], [@CR39]\].

In the context of social disadvantage, Leese et al, in a Scottish study, showed a link between social disadvantage and diabetic foot disease \[[@CR21]\], with the most deprived quintile having a 1.7-fold increased risk of developing a foot ulcer. Access to a GP or hospital clinic was not associated with foot ulceration or amputation. We have previously shown that socially disadvantaged individuals have a predisposition to developing painful peripheral neuropathy, an important determinant of foot ulceration in both type 1 and type 2 diabetes \[[@CR40]\]. Regarding the increased death rate in individuals with an established foot ulcer, the dominant prognostic factor may be the effect of social disadvantage \[[@CR41], [@CR42]\]. Other factors include a greater intake of foods with a high glycaemic index and concomitant poorer glycaemic control \[[@CR43]\].

Among individuals with diabetes, a previous study has reported that both minor and major depression are strongly associated with increased mortality \[[@CR18]\]. Specifically, even after adjustment for age, sex, race/ethnicity and educational attainment, compared with the non-depressed group, minor and major depression were associated with a 1.67- and 2.30-fold increase in mortality, respectively. Depression itself was associated with greater socioeconomic disadvantage and lower educational attainment.

The current study has several strengths and weaknesses. It was a longitudinal study of all individuals attending GP practices in Cheshire, UK, with a median follow-up of 10.5 years. As a far as possible, GPs and practice nurses record any events and changes in medication. The area has a stable population, with little migration out of the area. One weakness is that, akin to all studies using primary-care data, our findings are subject to variability in the data entry of different GP practices. In relation to this, a record of more than one episode of foot ulceration could not be ascribed in all cases as true multiple episodes of new foot ulcers. Second, we did not have the actual anatomical location of the foot ulcers. There is potential for under-reporting of foot ulceration. However, the area of the UK included in this study has a highly proactive podiatry service, led by one of the co-authors (GD), that engages closely with GP practices in the diagnosis and treatment of diabetes-related foot problems. Furthermore, diabetes management has changed a lot since 2004, particularly with respect to more aggressive BP and lipid management, with recent studies showing that rates of cardiovascular death have declined. This issue affects prospective studies in this area. Another weakness is that there was no specific information in the GP-coded records on psychological symptoms (including depression), educational attainment and occupation, all of which could potentially affect foot ulceration rates and impact mortality.

Foot problems in diabetes continue to challenge the clinicians who care for these individuals. Not only are foot ulcers associated with morbidity and disability, but they also lead to significant impairment of quality of life \[[@CR44]\]. It is known that poor health-related quality of life is a predictive factor for major amputation and mortality \[[@CR22]\]. We found increased mortality in individuals with a history of foot ulceration, and this risk increased per quintile of deprivation. This key finding highlights the importance of targeting resources to less socioeconomically advantaged individuals with diabetes in any community, particularly when they have a foot ulcer.

A proactive multidisciplinary approach is warranted to manage foot problems in these individuals. Such an approach should involve actively targeting cardiovascular risk factors at the GP practice level using case identification. This may reduce the incidence of foot ulceration and, subsequently, the associated increased mortality. Recognising and reducing the risk of death from associated comorbid conditions can save not only the limb but also, ultimately, a person's life. The educational attainment of the individual must be considered for them to appreciate the significance of their own diabetic foot ulceration. Data pertaining to educational attainment were not available for our analysis.

In summary, this study confirms the high mortality of individuals with diabetes-related foot ulcers, in addition to the well established associated substantial morbidity and disability. Socioeconomic disadvantage is an independent predictor of mortality in individuals with diabetes with a foot ulcer and of the occurrence of foot ulceration in people with diabetes. This highlights the importance of taking socioeconomic disadvantage into account when planning future diabetes services.
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Some of these data were presented at a Diabetes UK professional conference and the ADA's 76th Scientific Sessions, both in 2016.
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